These are special types of starch used in medicine. They are modified starches that can help carry things around in your body, like blood products. They are used in certain types of blood transfusions.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Hydroxyethyl starch, often shortened to HES, is a hospital IV fluid made from chemically modified corn starch. It is used to treat hypovolemia, meaning too little fluid in the bloodstream, which can happen after heavy bleeding, major surgery, severe burns or shock. In the US, the FDA-approved products have been hetastarch (as Hespan, Hextend and a generic) and Voluven, a related starch with smaller molecules. Pentaspan, a similar pentastarch product, was used in Canada but is no longer marketed there. Since 2021, the US Food and Drug Administration (FDA) has said these products should be used only when adequate alternative treatment is unavailable, because they raise the risk of death, kidney injury and bleeding in several groups of patients. In practice, most people who need fluids now receive crystalloids (salt-based solutions such as saline or lactated Ringer's), albumin or blood products instead. HES expands volume but is not a substitute for blood or plasma. One version of hetastarch has a second, quite different use: it is added to the collection machine during leukapheresis, a procedure that gathers white blood cells called granulocytes from a donor, because it helps red cells settle out and improves the yield.
Blood vessels hold on to fluid partly because of large molecules in plasma, such as the protein albumin, that pull water toward them. Most salt solutions leak out of the vessels into the surrounding tissues fairly quickly. HES molecules are too large to cross the vessel wall easily, so they keep more of the infused fluid inside the circulation, which supports blood pressure and blood flow to organs. The label describes the effect as similar to 5% albumin. The expansion fades over roughly a day or two as smaller starch molecules are filtered out by the kidneys. Some of the starch is cleared much more slowly, and deposits have been found in tissues, including nerves in the skin. Large starch molecules also interfere with clotting proteins. These two features help explain the main risks: kidney damage, bleeding problems and long-lasting itching.
HES is given only by a clinician, as an infusion into a vein, usually in an operating room, intensive care unit or emergency setting. It comes as a ready-mixed 6% solution in either salt water or a balanced electrolyte fluid. The amount depends on how much blood or fluid has been lost; for hetastarch in adults, 500 to 1,000 mL is typical, and the label warns that higher doses add to the risk of fluid overload and bleeding. For leukapheresis, the solution is mixed into the donor's blood inside the collection machine rather than given as a separate treatment. There is no home or outpatient form, so there is no schedule for patients to follow.
Because HES is often given to people who are already very ill, its effects can be hard to separate from the illness itself. The problems the label lists most often are allergic reactions, impaired blood clotting, dilution of the blood (lower red cell and protein levels), fluid overload and an excess of acid in the blood. Fluid overload can cause swelling and shortness of breath, especially in people with heart or lung problems. Some people develop persistent itching, which has been linked to starch deposits in nerves. Serious allergic reactions, including anaphylaxis, are rare but have been fatal. Because the product is made from corn starch, people with a corn allergy can react to it. The infusion is stopped at the first sign of a reaction, and the hospital team treats it on the spot.
The FDA requires a boxed warning, its most serious label warning, on all HES products. It states that HES increases the risk of death, kidney injury and clotting problems, and that it should not be used unless adequate alternative treatment is unavailable. The evidence comes from trials and large studies in critically ill people (including those with sepsis, a severe body-wide response to infection), people having surgery and people injured by blunt trauma. A 2018 Cochrane review of fluid resuscitation in critically ill people found that starches probably make little or no difference to survival compared with salt solutions, while slightly increasing the need for blood transfusion and dialysis. HES should be avoided in people who already have kidney disease. It is not recommended during or just after heart surgery that uses a heart-lung bypass machine, because it can worsen bleeding when clotting is already disturbed. Repeated doses over several days have caused serious bleeding, including bleeding in the brain, in people with a type of brain hemorrhage. Anyone with a corn allergy, heart failure or a bleeding disorder should make sure the team knows. Safety in pregnancy is not established, so it is used only if the expected benefit outweighs the risk.
Most people who receive HES are in hospital and may not be aware of which IV fluids they were given, so it is reasonable to ask. During and after the infusion, the team watches blood pressure, breathing, urine output and blood tests of kidney function, clotting and liver function. Kidney injury can appear late. The label advises monitoring kidney function for at least 90 days, because dialysis has been needed up to three months after treatment. The FDA advises people who received HES to report right away any change in how often they urinate, how much or what color it is, blood in the urine, difficulty urinating, new swelling of the legs, ankles, feet, face or hands, unusual weakness or tiredness, nausea and vomiting, or shortness of breath. Keeping follow-up blood tests after discharge is part of the treatment, not an optional extra.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Hydroxyethyl Starch Derivatives, what you've noticed, or ask the community a question.